139 related articles for article (PubMed ID: 7522595)
1. Mechanism of the action of angiotensin-converting enzyme inhibitors on agonist-induced Ca2+ influx.
Zhu Z; Tepel M; Neusser M; Zidek W
J Vasc Res; 1994; 31(5):265-70. PubMed ID: 7522595
[TBL] [Abstract][Full Text] [Related]
2. Cellular protective action of angiotensin converting enzyme inhibitors.
Tepel M; Heidenreich S; Zhu Z; Zidek W
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():61-3. PubMed ID: 9288548
[TBL] [Abstract][Full Text] [Related]
3. [Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
Meyer-Lehnert H; Jahnecke C; Kappes-Horn K; Kramer HJ
Klin Wochenschr; 1991; 69 Suppl 24():45-9. PubMed ID: 1650862
[TBL] [Abstract][Full Text] [Related]
4. Effect of captopril on vasoconstriction and Ca2+ fluxes in aortic smooth muscle.
Zhu Z; Tepel M; Neusser M; Mehring N; Zidek W
Hypertension; 1993 Dec; 22(6):806-11. PubMed ID: 8244513
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II responses after protein kinase C activation in vascular smooth muscle cells of spontaneously hypertensive rats.
Neusser M; Tepel M; Zidek W
J Cardiovasc Pharmacol; 1993 May; 21(5):749-53. PubMed ID: 7685444
[TBL] [Abstract][Full Text] [Related]
6. Effects of captopril and enalapril on intracellular Ca2+ in vascular smooth muscle cell.
Qi JH; Zhang L; Wang J; Wei PJ; Gu PK; Jin ZJ; Huang MZ; Wang HY
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):142-5. PubMed ID: 9772664
[TBL] [Abstract][Full Text] [Related]
7. Captopril inhibits the agonist-induced increase of cytosolic free Ca2+ in glomerular mesangial cells.
Tepel M; Heidenreich S; Zhu Z; Walter M; Nofer JR; Zidek W
Kidney Int; 1994 Sep; 46(3):696-702. PubMed ID: 7996790
[TBL] [Abstract][Full Text] [Related]
8. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
9. Augmented Ca2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats.
Yoo HJ; Kozaki K; Akishita M; Watanabe M; Eto M; Nagano K; Sudo N; Hashimoto M; Kim S; Yoshizumi M; Toba K; Ouchi Y
Atherosclerosis; 1997 Jun; 131(2):167-75. PubMed ID: 9199269
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition during development alters calcium regulation in adult hypertensive rats.
Traub O; Webb RC
J Pharmacol Exp Ther; 1993 Dec; 267(3):1503-8. PubMed ID: 7505333
[TBL] [Abstract][Full Text] [Related]
11. Effects of captopril and enalaprilat on intracellular Ca2+ content in isolated cardiomyocytes from rats.
Wang J; Zhang L; Qi JH; Zhang PJ; Wei PJ; Gu PK; Jin ZJ
Zhongguo Yao Li Xue Bao; 1996 May; 17(3):233-5. PubMed ID: 9812744
[TBL] [Abstract][Full Text] [Related]
12. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
13. In vitro tissue potencies of converting enzyme inhibitors. Prodrug activation by kidney esterase.
Grima M; Welsch C; Michel B; Barthelmebs M; Imbs JL
Hypertension; 1991 Apr; 17(4):492-6. PubMed ID: 2013476
[TBL] [Abstract][Full Text] [Related]
14. Receptor-operated calcium-permeable channels in vascular smooth muscle.
Rüegg UT; Wallnöfer A; Weir S; Cauvin C
J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S49-58. PubMed ID: 2478825
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II and vasopressin modulate intracellular free magnesium in vascular smooth muscle cells through Na+-dependent protein kinase C pathways.
Touyz RM; Schiffrin EL
J Biol Chem; 1996 Oct; 271(40):24353-8. PubMed ID: 8798689
[TBL] [Abstract][Full Text] [Related]
16. Evidence for stimulation of neutrophil degranulation by selected angiotensin converting enzyme inhibitors in vitro.
Miselis J; Siminiak T; Wysocki H
J Hum Hypertens; 1994 Aug; 8(8):565-9. PubMed ID: 7990082
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca2+ channel inhibition in cultured vascular smooth muscle cells.
Toshiro M; Ueno T; Tanaka M; Oka H; Miyamotq T; Osajima K; Matsumoto K
Hypertens Res; 2005 Jun; 28(6):545-52. PubMed ID: 16231761
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z
Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945
[TBL] [Abstract][Full Text] [Related]
20. In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells.
Baudin B; Drouet L
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S37-42. PubMed ID: 2483427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
